|
| Analyst
Scorecard | | Analyst: | Somaiya, Ian | EPS
Est. Accuracy: | Not Avl.
| | Broker: | Thomas Weisel Partners | Recommendation
Performance: | 
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
| Not Avl.
|
3.0%
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
AFFY
|
Affymax Inc
| 
|
6
| | | | |
AMGN
|
Amgen Inc
|
|
19
| | | | |
AMLN
|
Amylin Pharmaceuticals Inc
|
|
17
| | | | |
ARRY
|
Array Biopharma Inc
|
|
9
| | | | |
BIIB
|
Biogen Idec Incorporated
| 
|
20
| | | | |
DCGN
|
Decode Genetics Inc
|
|
2
| | | | |
DNA
|
Genentech Inc.
|
|
20
| | | | |
GILD
|
Gilead Sciences Inc
|
|
25
| | | | |
HGSI
|
Human Genome Sciences Incorporat
|
|
11
| | | | |
MBRX
|
Metabasis Therapeutics Inc
|
|
6
| | | | |
NBIX
|
Neurocrine Biosciences Inc
|
|
11
| | | | |
RIGL
|
Rigel Pharmaceuticals
|
|
6
| | | | |
THRX
|
Theravance Inc
|
|
6
| | | |
| Other Stocks Covered
| |
Vertex Pharmaceuticals Inc (VRTX)
|
| | |
|
|
|